aluates Reports

$ 0.0

Automative

Global Pneumococcal 13-valent Conjugate Vaccine Market Research Report 2024

Published Date: November 2024

Report Code: QYRE-Auto-22Y18368

BUY CHAPTERS

Global Pneumococcal 13-valent Conjugate Vaccine Market Research Report 2024

Code: QYRE-Auto-22Y18368

Report

November 2024

Pages:74

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Walvax

Biokangtai

Pneumococcal 13-valent Conjugate Vaccine Market

The Pneumococcal 13-valent Conjugate Vaccine (PCV13) is a vaccine designed to protect against infections caused by Streptococcus pneumoniae bacteria, commonly known as pneumococcus. It targets 13 specific strains (or serotypes) of the bacteria, which are responsible for severe illnesses such as pneumonia, meningitis, and sepsis. By preventing these infections, PCV13 is particularly important in protecting young children, and people with weakened immune systems.

The global Pneumococcal 13-valent Conjugate Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Pneumococcal 13-valent Conjugate Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Pneumococcal 13-valent Conjugate Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Pneumococcal 13-valent Conjugate Vaccine include Pfizer, Walvax, BIOKANGTAI, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pneumococcal 13-valent Conjugate Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pneumococcal 13-valent Conjugate Vaccine.

The Pneumococcal 13-valent Conjugate Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Pneumococcal 13-valent Conjugate Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pneumococcal 13-valent Conjugate Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pneumococcal 13-valent Conjugate Vaccine Market Report

Report Metric	Details
Report Name	Pneumococcal 13-valent Conjugate Vaccine Market
Segment by Type	0.5ml Other
Segment by Application	Hospital Clinic
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Pfizer, Walvax, BIOKANGTAI
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pneumococcal 13-valent Conjugate Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pneumococcal 13-valent Conjugate Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pneumococcal 13-valent Conjugate Vaccine Market report?

Ans: The main players in the Pneumococcal 13-valent Conjugate Vaccine Market are Pfizer, Walvax, BIOKANGTAI

What are the Application segmentation covered in the Pneumococcal 13-valent Conjugate Vaccine Market report?

Ans: The Applications covered in the Pneumococcal 13-valent Conjugate Vaccine Market report are Hospital, Clinic

What are the Type segmentation covered in the Pneumococcal 13-valent Conjugate Vaccine Market report?

Ans: The Types covered in the Pneumococcal 13-valent Conjugate Vaccine Market report are 0.5ml, Other

Recommended Reports

Pneumococcal Vaccine Markets

Meningitis & Bacterial Vaccines

Vaccine Types & Technologies

1 Pneumococcal 13-valent Conjugate Vaccine Market Overview

1.1 Product Definition

1.2 Pneumococcal 13-valent Conjugate Vaccine by Type

1.2.1 Global Pneumococcal 13-valent Conjugate Vaccine Market Value Comparison by Type (2024-2030)

1.2.2 0.5ml

1.2.3 Other

1.3 Pneumococcal 13-valent Conjugate Vaccine by Application

1.3.1 Global Pneumococcal 13-valent Conjugate Vaccine Market Value by Application (2024-2030)

1.3.2 Hospital

1.3.3 Clinic

1.4 Global Pneumococcal 13-valent Conjugate Vaccine Market Size Estimates and Forecasts

1.4.1 Global Pneumococcal 13-valent Conjugate Vaccine Revenue 2019-2030

1.4.2 Global Pneumococcal 13-valent Conjugate Vaccine Sales 2019-2030

1.4.3 Global Pneumococcal 13-valent Conjugate Vaccine Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Pneumococcal 13-valent Conjugate Vaccine Market Competition by Manufacturers

2.1 Global Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Manufacturers (2019-2024)

2.2 Global Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Pneumococcal 13-valent Conjugate Vaccine Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Pneumococcal 13-valent Conjugate Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Pneumococcal 13-valent Conjugate Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Pneumococcal 13-valent Conjugate Vaccine, Product Type & Application

2.7 Global Key Manufacturers of Pneumococcal 13-valent Conjugate Vaccine, Date of Enter into This Industry

2.8 Global Pneumococcal 13-valent Conjugate Vaccine Market Competitive Situation and Trends

2.8.1 Global Pneumococcal 13-valent Conjugate Vaccine Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Pneumococcal 13-valent Conjugate Vaccine Players Market Share by Revenue

2.8.3 Global Pneumococcal 13-valent Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Pneumococcal 13-valent Conjugate Vaccine Market Scenario by Region

3.1 Global Pneumococcal 13-valent Conjugate Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Pneumococcal 13-valent Conjugate Vaccine Sales by Region: 2019-2030

3.2.1 Global Pneumococcal 13-valent Conjugate Vaccine Sales by Region: 2019-2024

3.2.2 Global Pneumococcal 13-valent Conjugate Vaccine Sales by Region: 2025-2030

3.3 Global Pneumococcal 13-valent Conjugate Vaccine Revenue by Region: 2019-2030

3.3.1 Global Pneumococcal 13-valent Conjugate Vaccine Revenue by Region: 2019-2024

3.3.2 Global Pneumococcal 13-valent Conjugate Vaccine Revenue by Region: 2025-2030

3.4 North America Pneumococcal 13-valent Conjugate Vaccine Market Facts & Figures by Country

3.4.1 North America Pneumococcal 13-valent Conjugate Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Pneumococcal 13-valent Conjugate Vaccine Sales by Country (2019-2030)

3.4.3 North America Pneumococcal 13-valent Conjugate Vaccine Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Pneumococcal 13-valent Conjugate Vaccine Market Facts & Figures by Country

3.5.1 Europe Pneumococcal 13-valent Conjugate Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Pneumococcal 13-valent Conjugate Vaccine Sales by Country (2019-2030)

3.5.3 Europe Pneumococcal 13-valent Conjugate Vaccine Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Pneumococcal 13-valent Conjugate Vaccine Market Facts & Figures by Region

3.6.1 Asia Pacific Pneumococcal 13-valent Conjugate Vaccine Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Pneumococcal 13-valent Conjugate Vaccine Sales by Region (2019-2030)

3.6.3 Asia Pacific Pneumococcal 13-valent Conjugate Vaccine Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Pneumococcal 13-valent Conjugate Vaccine Market Facts & Figures by Country

3.7.1 Latin America Pneumococcal 13-valent Conjugate Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Pneumococcal 13-valent Conjugate Vaccine Sales by Country (2019-2030)

3.7.3 Latin America Pneumococcal 13-valent Conjugate Vaccine Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Pneumococcal 13-valent Conjugate Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Pneumococcal 13-valent Conjugate Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Pneumococcal 13-valent Conjugate Vaccine Sales by Country (2019-2030)

3.8.3 Middle East and Africa Pneumococcal 13-valent Conjugate Vaccine Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Pneumococcal 13-valent Conjugate Vaccine Sales by Type (2019-2030)

4.1.1 Global Pneumococcal 13-valent Conjugate Vaccine Sales by Type (2019-2024)

4.1.2 Global Pneumococcal 13-valent Conjugate Vaccine Sales by Type (2025-2030)

4.1.3 Global Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Type (2019-2030)

4.2 Global Pneumococcal 13-valent Conjugate Vaccine Revenue by Type (2019-2030)

4.2.1 Global Pneumococcal 13-valent Conjugate Vaccine Revenue by Type (2019-2024)

4.2.2 Global Pneumococcal 13-valent Conjugate Vaccine Revenue by Type (2025-2030)

4.2.3 Global Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Type (2019-2030)

4.3 Global Pneumococcal 13-valent Conjugate Vaccine Price by Type (2019-2030)

5 Segment by Application

5.1 Global Pneumococcal 13-valent Conjugate Vaccine Sales by Application (2019-2030)

5.1.1 Global Pneumococcal 13-valent Conjugate Vaccine Sales by Application (2019-2024)

5.1.2 Global Pneumococcal 13-valent Conjugate Vaccine Sales by Application (2025-2030)

5.1.3 Global Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Application (2019-2030)

5.2 Global Pneumococcal 13-valent Conjugate Vaccine Revenue by Application (2019-2030)

5.2.1 Global Pneumococcal 13-valent Conjugate Vaccine Revenue by Application (2019-2024)

5.2.2 Global Pneumococcal 13-valent Conjugate Vaccine Revenue by Application (2025-2030)

5.2.3 Global Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Application (2019-2030)

5.3 Global Pneumococcal 13-valent Conjugate Vaccine Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Pfizer

6.1.1 Pfizer Company Information

6.1.2 Pfizer Description and Business Overview

6.1.3 Pfizer Pneumococcal 13-valent Conjugate Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Pfizer Pneumococcal 13-valent Conjugate Vaccine Product Portfolio

6.1.5 Pfizer Recent Developments/Updates

6.2 Walvax

6.2.1 Walvax Company Information

6.2.2 Walvax Description and Business Overview

6.2.3 Walvax Pneumococcal 13-valent Conjugate Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Walvax Pneumococcal 13-valent Conjugate Vaccine Product Portfolio

6.2.5 Walvax Recent Developments/Updates

6.3 BIOKANGTAI

6.3.1 BIOKANGTAI Company Information

6.3.2 BIOKANGTAI Description and Business Overview

6.3.3 BIOKANGTAI Pneumococcal 13-valent Conjugate Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.3.4 BIOKANGTAI Pneumococcal 13-valent Conjugate Vaccine Product Portfolio

6.3.5 BIOKANGTAI Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Pneumococcal 13-valent Conjugate Vaccine Industry Chain Analysis

7.2 Pneumococcal 13-valent Conjugate Vaccine Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Pneumococcal 13-valent Conjugate Vaccine Production Mode & Process

7.4 Pneumococcal 13-valent Conjugate Vaccine Sales and Marketing

7.4.1 Pneumococcal 13-valent Conjugate Vaccine Sales Channels

7.4.2 Pneumococcal 13-valent Conjugate Vaccine Distributors

7.5 Pneumococcal 13-valent Conjugate Vaccine Customers

8 Pneumococcal 13-valent Conjugate Vaccine Market Dynamics

8.1 Pneumococcal 13-valent Conjugate Vaccine Industry Trends

8.2 Pneumococcal 13-valent Conjugate Vaccine Market Drivers

8.3 Pneumococcal 13-valent Conjugate Vaccine Market Challenges

8.4 Pneumococcal 13-valent Conjugate Vaccine Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Walvax

Biokangtai

List of Tables

Table 1. Global Pneumococcal 13-valent Conjugate Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Pneumococcal 13-valent Conjugate Vaccine Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global Pneumococcal 13-valent Conjugate Vaccine Market Competitive Situation by Manufacturers in 2023

Table 4. Global Pneumococcal 13-valent Conjugate Vaccine Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Pneumococcal 13-valent Conjugate Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Pneumococcal 13-valent Conjugate Vaccine Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Pneumococcal 13-valent Conjugate Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Pneumococcal 13-valent Conjugate Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Pneumococcal 13-valent Conjugate Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Pneumococcal 13-valent Conjugate Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of Pneumococcal 13-valent Conjugate Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Pneumococcal 13-valent Conjugate Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumococcal 13-valent Conjugate Vaccine as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Pneumococcal 13-valent Conjugate Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Pneumococcal 13-valent Conjugate Vaccine Sales by Region (2019-2024) & (K Units)

Table 18. Global Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Region (2019-2024)

Table 19. Global Pneumococcal 13-valent Conjugate Vaccine Sales by Region (2025-2030) & (K Units)

Table 20. Global Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Region (2025-2030)

Table 21. Global Pneumococcal 13-valent Conjugate Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Region (2019-2024)

Table 23. Global Pneumococcal 13-valent Conjugate Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Region (2025-2030)

Table 25. North America Pneumococcal 13-valent Conjugate Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Pneumococcal 13-valent Conjugate Vaccine Sales by Country (2019-2024) & (K Units)

Table 27. North America Pneumococcal 13-valent Conjugate Vaccine Sales by Country (2025-2030) & (K Units)

Table 28. North America Pneumococcal 13-valent Conjugate Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Pneumococcal 13-valent Conjugate Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Pneumococcal 13-valent Conjugate Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Pneumococcal 13-valent Conjugate Vaccine Sales by Country (2019-2024) & (K Units)

Table 32. Europe Pneumococcal 13-valent Conjugate Vaccine Sales by Country (2025-2030) & (K Units)

Table 33. Europe Pneumococcal 13-valent Conjugate Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Pneumococcal 13-valent Conjugate Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Pneumococcal 13-valent Conjugate Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Pneumococcal 13-valent Conjugate Vaccine Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Pneumococcal 13-valent Conjugate Vaccine Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Pneumococcal 13-valent Conjugate Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Pneumococcal 13-valent Conjugate Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Pneumococcal 13-valent Conjugate Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Pneumococcal 13-valent Conjugate Vaccine Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Pneumococcal 13-valent Conjugate Vaccine Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Pneumococcal 13-valent Conjugate Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa Pneumococcal 13-valent Conjugate Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa Pneumococcal 13-valent Conjugate Vaccine Sales by Country (2019-2024) & (K Units)

Table 47. Middle East and Africa Pneumococcal 13-valent Conjugate Vaccine Sales by Country (2025-2030) & (K Units)

Table 48. Middle East and Africa Pneumococcal 13-valent Conjugate Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa Pneumococcal 13-valent Conjugate Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Pneumococcal 13-valent Conjugate Vaccine Sales (K Units) by Type (2019-2024)

Table 51. Global Pneumococcal 13-valent Conjugate Vaccine Sales (K Units) by Type (2025-2030)

Table 52. Global Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Type (2019-2024)

Table 53. Global Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Type (2025-2030)

Table 54. Global Pneumococcal 13-valent Conjugate Vaccine Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Pneumococcal 13-valent Conjugate Vaccine Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Type (2019-2024)

Table 57. Global Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Type (2025-2030)

Table 58. Global Pneumococcal 13-valent Conjugate Vaccine Price (US$/Unit) by Type (2019-2024)

Table 59. Global Pneumococcal 13-valent Conjugate Vaccine Price (US$/Unit) by Type (2025-2030)

Table 60. Global Pneumococcal 13-valent Conjugate Vaccine Sales (K Units) by Application (2019-2024)

Table 61. Global Pneumococcal 13-valent Conjugate Vaccine Sales (K Units) by Application (2025-2030)

Table 62. Global Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Application (2019-2024)

Table 63. Global Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Application (2025-2030)

Table 64. Global Pneumococcal 13-valent Conjugate Vaccine Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Pneumococcal 13-valent Conjugate Vaccine Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Application (2019-2024)

Table 67. Global Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Application (2025-2030)

Table 68. Global Pneumococcal 13-valent Conjugate Vaccine Price (US$/Unit) by Application (2019-2024)

Table 69. Global Pneumococcal 13-valent Conjugate Vaccine Price (US$/Unit) by Application (2025-2030)

Table 70. Pfizer Company Information

Table 71. Pfizer Description and Business Overview

Table 72. Pfizer Pneumococcal 13-valent Conjugate Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Pfizer Pneumococcal 13-valent Conjugate Vaccine Product

Table 74. Pfizer Recent Developments/Updates

Table 75. Walvax Company Information

Table 76. Walvax Description and Business Overview

Table 77. Walvax Pneumococcal 13-valent Conjugate Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Walvax Pneumococcal 13-valent Conjugate Vaccine Product

Table 79. Walvax Recent Developments/Updates

Table 80. BIOKANGTAI Company Information

Table 81. BIOKANGTAI Description and Business Overview

Table 82. BIOKANGTAI Pneumococcal 13-valent Conjugate Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. BIOKANGTAI Pneumococcal 13-valent Conjugate Vaccine Product

Table 84. BIOKANGTAI Recent Developments/Updates

Table 85. Key Raw Materials Lists

Table 86. Raw Materials Key Suppliers Lists

Table 87. Pneumococcal 13-valent Conjugate Vaccine Distributors List

Table 88. Pneumococcal 13-valent Conjugate Vaccine Customers List

Table 89. Pneumococcal 13-valent Conjugate Vaccine Market Trends

Table 90. Pneumococcal 13-valent Conjugate Vaccine Market Drivers

Table 91. Pneumococcal 13-valent Conjugate Vaccine Market Challenges

Table 92. Pneumococcal 13-valent Conjugate Vaccine Market Restraints

Table 93. Research Programs/Design for This Report

Table 94. Key Data Information from Secondary Sources

Table 95. Key Data Information from Primary Sources

Table 96. Authors List of This Report

List of Figures

Figure 1. Product Picture of Pneumococcal 13-valent Conjugate Vaccine

Figure 2. Global Pneumococcal 13-valent Conjugate Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Pneumococcal 13-valent Conjugate Vaccine Market Share by Type: 2023 & 2030

Figure 4. 0.5ml Product Picture

Figure 5. Other Product Picture

Figure 6. Global Pneumococcal 13-valent Conjugate Vaccine Market Value by Application (2024-2030) & (US$ Million)

Figure 7. Global Pneumococcal 13-valent Conjugate Vaccine Market Share by Application: 2023 & 2030

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Global Pneumococcal 13-valent Conjugate Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 11. Global Pneumococcal 13-valent Conjugate Vaccine Market Size (2019-2030) & (US$ Million)

Figure 12. Global Pneumococcal 13-valent Conjugate Vaccine Sales (2019-2030) & (K Units)

Figure 13. Global Pneumococcal 13-valent Conjugate Vaccine Average Price (US$/Unit) & (2019-2030)

Figure 14. Pneumococcal 13-valent Conjugate Vaccine Report Years Considered

Figure 15. Pneumococcal 13-valent Conjugate Vaccine Sales Share by Manufacturers in 2023

Figure 16. Global Pneumococcal 13-valent Conjugate Vaccine Revenue Share by Manufacturers in 2023

Figure 17. Global 5 and 10 Largest Pneumococcal 13-valent Conjugate Vaccine Players: Market Share by Revenue in Pneumococcal 13-valent Conjugate Vaccine in 2023

Figure 18. Pneumococcal 13-valent Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 19. Global Pneumococcal 13-valent Conjugate Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 20. North America Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Country (2019-2030)

Figure 21. North America Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Country (2019-2030)

Figure 22. United States Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 23. Canada Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Europe Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Country (2019-2030)

Figure 25. Europe Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Country (2019-2030)

Figure 26. Germany Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. France Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. U.K. Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Italy Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Russia Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Region (2019-2030)

Figure 32. Asia Pacific Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Region (2019-2030)

Figure 33. China Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Japan Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. South Korea Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. India Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Australia Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. China Taiwan Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Southeast Asia Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Latin America Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Country (2019-2030)

Figure 41. Mexico Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Brazil Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Argentina Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Colombia Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Middle East and Africa Pneumococcal 13-valent Conjugate Vaccine Sales Market Share by Country (2019-2030)

Figure 46. Middle East and Africa Pneumococcal 13-valent Conjugate Vaccine Revenue Market Share by Country (2019-2030)

Figure 47. Turkey Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. UAE Pneumococcal 13-valent Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Global Sales Market Share of Pneumococcal 13-valent Conjugate Vaccine by Type (2019-2030)

Figure 51. Global Revenue Market Share of Pneumococcal 13-valent Conjugate Vaccine by Type (2019-2030)

Figure 52. Global Pneumococcal 13-valent Conjugate Vaccine Price (US$/Unit) by Type (2019-2030)

Figure 53. Global Sales Market Share of Pneumococcal 13-valent Conjugate Vaccine by Application (2019-2030)

Figure 54. Global Revenue Market Share of Pneumococcal 13-valent Conjugate Vaccine by Application (2019-2030)

Figure 55. Global Pneumococcal 13-valent Conjugate Vaccine Price (US$/Unit) by Application (2019-2030)

Figure 56. Pneumococcal 13-valent Conjugate Vaccine Value Chain

Figure 57. Pneumococcal 13-valent Conjugate Vaccine Production Process

Figure 58. Channels of Distribution (Direct Vs Distribution)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

13 Valent Pneumococcal Polysaccharide Conjugate Vaccine PCV13 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global 23 Valent Pneumococcal Polysaccharide Vaccine Market Research Report 2024

Global 13 Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Research Report 2024

Global Polyvalent Streptococcus Pneumococcal Vaccines Market Research Report 2025

Pneumococcal Bacteria Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pneumococcal Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027

Global Pneumococcal Vaccination Market Research Report 2025

Global Polyvalent Streptococcus Pneumoniae Active Immunizing Agent Market Research Report 2024

Pneumococcal Vaccine Polyvalent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pneumococcal Conjugate Vaccine PCV Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pneumonia Vaccine Market Insights Forecast to 2030

Multivalent Pneumococcal Conjugate Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccine for Non infectious Meningitis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

23 valent Pneumococcal Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Streptococcus Pneumoniae Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Recombinant Human Papillomavirus 9 Valent Vaccine Market Research Report 2024

Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Research Report 2025

Global Pneumococcal Polysaccharide Vaccine Market Research Report 2024

Global Vaccine Conjugate Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions